Carbetocin Nasal Spray, Placebo to match carbetocin 11.4 mg/ml (2ml /vial)
ACP-101-302
Phase 3 small_molecule active
Quick answer
Carbetocin Nasal Spray, Placebo to match carbetocin 11.4 mg/ml (2ml /vial) for Hyperphagia related behaviour associated with Prader-Willi Syndrome (PWS) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Hyperphagia related behaviour associated with Prader-Willi Syndrome (PWS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active